To view the PDF file, sign up for a MySharenet subscription.
Back to PHP SENS
PHPROP:  2,098   +14 (+0.67%)  29/04/2026 19:00

PRIMARY HEALTH PROPERTIES PLC - Results of AGM voting

Release Date: 29/04/2026 14:30
Code(s): PHP     PDF:  
Wrap Text
Results of AGM voting

Primary Health Properties PLC
(Incorporated in the United Kingdom)
Company Number: 3033634
LSE Share Code: PHP
JSE Share Code: PHP
ISIN Code: GB00BYRJ5J14
LEI: 213800Y5CJHXOATK7X11
("PHP" or the "Company")




29 April 2026


                                             Results of AGM voting


Primary Health Properties PLC (the "Company" or "PHP")) announces that at the Annual General Meeting of
the Company held today 29 April 2026, all of the resolutions, as set out in full in the Notice of Meeting, were
duly passed on a poll by the requisite majority. Any proxy votes which were at the discretion of the Chair have
been included in the "For" total.

For information the votes cast were as follows:
Resolution                             For (including          Against                Votes Total     % of          Withheld1
                                       discretionary)                                                 ISC
                                                                                                      Voted
                                    Votes             %        Votes          %
1. To receive the Annual Report
and Accounts for the year ended
31 December 2025
                                     1,641,121,456   99.97     414,633        0.03     1,641,536,089   63.25%      13,808,004
2. To approve the Directors'
remuneration report
                                     1,600,369,057   96.75     53,677,283     3.25     1,654,046,340   63.74%      1,297,753
3. To approve the Company's
dividend policy
                                     1,654,337,973   99.97     474,258        0.03     1,654,812,231   63.77%      531,862
4. To authorise a scrip dividend
                                     1,652,654,869   99.88     1,976,918      0.12     1,654,631,787   63.76%      712,306
5. To approve the re-
appointment of Deloitte LLP as
auditor
                                     1,552,494,333   93.90     100,925,107    6.10     1,653,419,440   63.71%      1,924,653
6. To authorise the Audit
Committee to fix the auditor's
remuneration
                                     1,637,186,339   99.02     16,240,701     0.98     1,653,427,040   63.71%      1,917,053
7. To re-elect Harry Hyman as a
Director
                                     1,475,299,216   89.22     178,293,697    10.78    1,653,592,913   63.72%      1,751,180
8. To re-elect Mark Davies as a
Director
                                     1,648,200,859   99.63     6,114,301      0.37     1,654,315,160   63.75%      1,028,933
9. To re-elect Richard Howell as
a Director
                                     1,648,078,879   99.62     6,240,256      0.38     1,654,319,135   63.75%      1,024,958
10. To re-elect Ian Krieger as a
Director                             1,622,703,426   98.09     31,605,943     1.91     1,654,309,369   63.75%      1,034,724

11. To re-elect Ivonne Cantú as
a Director
                                     1,544,184,456   93.34     110,113,205    6.66     1,654,297,661    63.75%     1,046,432
12. To elect Jonathan Davies as
a Director
                                     1,653,139,239   99.93     1,165,720      0.07     1,654,304,959    63.75%     1,039,134
13. To re-elect Laure Duhot as a
Director
                                     1,623,310,804   98.86     18,737,792     1.14     1,642,048,596    63.27%     13,295,497
14. To re-elect Dr Bandhana
Rawal as a Director
                                     1,635,565,662   98.87     18,717,208     1.13     1,654,282,870    63.75%     1,061,223
15. To authorise the making of
political donations
                                     1,574,889,087   95.55     73,350,687     4.45     1,648,239,774    63.51%     7,098,319
16. To approve Directors' fees
under the Articles
                                     1,643,074,801   99.40     9,934,462      0.60     1,653,009,263    63.70%     2,334,830
17. To authorise the Directors
to allot shares
                                     1,560,331,740   94.31     94,136,870     5.69     1,654,468,610    63.75%     875,483
18. To authorise the Directors to
disapply pre-emption rights *
                                     1,590,241,533   96.13     63,968,617     3.87     1,654,210,150    63.74%     1,133,943
19. To disapply pre-emption
rights in connection with an
acquisition or specified capital
investment*                          1,520,143,930   91.90     134,036,230    8.10     1,654,180,160    63.74%     1,163,933

20. To hold general meetings on
14 days' notice*
                                     1,561,992,106   94.40     92,651,641     5.60     1,654,643,747    63.76%     700,346

21. To purchase own shares*          1,648,291,629   99.66     5,608,765      0.34     1,653,900,394    63.73%     1,443,699



1A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes for or against a
resolution

* indicates a special resolution

A copy of the resolutions passed as special business at today's AGM will be submitted to the National
Storage Mechanism and will be available at https://data.fca.org.uk/#/nsm/nationalstoragemechanism


For further information contact:

Mark Davies CEO                                                   Richard Howell CFO

Primary Health Properties PLC                                     Primary Health Properties PLC



David Purcell Investor Relations

Primary Health Properties PLC

T: +44 (0) 7921 190 136

E: david.purcell@phpgroup.co.uk



Sodali & Co Financial PR

Elly Williamson/Louisa Henry/Saskia Bottomley
T: +44 (0) 207 250 1446 E: PHP@client.sodali.com



The Company has a primary listing on the London Stock Exchange and a secondary listing on the JSE Limited.



United Kingdom

Sponsor: PSG Capital

Date: 29-04-2026 02:30:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.